When should Smith-Lemli-Opitz syndrome be considered? A serie of 45 cases

被引:28
作者
Goldenberg, A
Chevy, F
Bernard, C
Wolf, C
Cormier-Daire, V
机构
[1] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Dept Med Genet, F-75743 Paris 15, France
[2] Univ Paris 06, Lab Spectrometrie Masse, Paris, France
[3] Hop St Antoine, Assistance Publ Hop Paris, Mol Biol Lab, F-75571 Paris, France
来源
ARCHIVES DE PEDIATRIE | 2003年 / 10卷 / 01期
关键词
Smith-Lemli-Opitz syndrome; mutations; genetics; infant;
D O I
10.1016/S0929-693X(03)00214-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction. - SLO (Smith-Lemli-Opitz) syndrome is an autosomal recessive multiple congenital malformations syndrome, including mental retardation, failure to thrive, craniofacial abnormalities, incomplete development of male genitalia, limb anomalies and various internal organ abnormalities. This syndrome is caused by a deficiency of cholesterol biosynthesis at the distal step of 7-dehydrocholesterol reductase (7DHCR). Patients and methods. - We have reviewed 45 cases of SLO syndrome and showed the large clinical spectrum of this syndrome. Results. - The prenatal diagnosis should be considered when dealing with antenatal growth retardation and visceral malformations. At birth, a normal weight does not systematically exclude the diagnosis. Diagnosis was more difficult for older children especially for girls and should be suspected on the association of mental retardation, autism, short stature and microcephaly. We found a correlation between low plasmatic cholesterol measurement and clinical severity. Phenotype-genotype correlation was difficult to establish. However, homozygosity for IVS8-1G>C splice site mutation was associated With severe phenotype. Conclusion. - Better understanding of the 7DHCR gene regulation factors and of the compensatory mechanism of foeto-maternal cholesterol transfer are necessary to explain the wide clinical spectrum of the SLO syndrome. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:4 / 10
页数:7
相关论文
共 24 条
[1]   Carrier frequency of the common mutation IVS8-IG>C in DHCR7 and estimate of the expected incidence of Smith-Lemli-Opitz syndrome [J].
Battaile, KP ;
Battaile, BC ;
Merkens, LS ;
Maslen, CL ;
Steiner, RD .
MOLECULAR GENETICS AND METABOLISM, 2001, 72 (01) :67-71
[2]   Teratogen-mediated inhibition of target tissue response to Shh signaling [J].
Cooper, MK ;
Porter, JA ;
Young, KE ;
Beachy, PA .
SCIENCE, 1998, 280 (5369) :1603-1607
[3]  
CORMDAIRE V, 1995, JOURN PAR PED, P93
[4]  
Cunniff C, 1997, AM J MED GENET, V68, P263, DOI 10.1002/(SICI)1096-8628(19970131)68:3<263::AID-AJMG4>3.0.CO
[5]  
2-N
[6]   Mutations in the Δ7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome [J].
Fitzky, BU ;
Witsch-Baumgartner, M ;
Erdel, M ;
Lee, JN ;
Paik, YK ;
Glossmann, H ;
Utermann, G ;
Moebius, FF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8181-8186
[7]  
Gaoua W, 2000, J LIPID RES, V41, P637
[8]   ABNORMAL CHOLESTEROL-METABOLISM IN THE SMITH-LEMLI-OPITZ SYNDROME - REPORT OF CLINICAL AND BIOCHEMICAL FINDINGS IN 4 PATIENTS AND TREATMENT IN ONE PATIENT [J].
IRONS, M ;
ELIAS, ER ;
TINT, GS ;
SALEN, G ;
FRIEDEN, R ;
BUIE, TM ;
AMPOLA, M .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 50 (04) :347-352
[9]  
Krajewska-Walasek M, 1999, CLIN DYSMORPHOL, V8, P29
[10]  
Nowaczyk MJM, 1998, AM J MED GENET, V78, P419, DOI 10.1002/(SICI)1096-8628(19980806)78:5<419::AID-AJMG5>3.0.CO